Life Technologies Expands CEERAM Food Safety Range to Global Market
News Jul 26, 2013
Life Technologies Corporation announced the expansion of its global food safety portfolio with the worldwide distribution of the RT-qPCR assays for the detection of Norovirus GI and Norovirus GII, Hepatitis A, and the Mengovirus Extraction Control Kit by CEERAM (the European Centre for Expertise and Research on Microbial Agents). Available only in Europe, Middle East and Africa until now, the solutions will now reach the global market through Life's supply channels.
Human Norovirus is the most common cause for food-borne disease outbreaks in the U.S. It causes 800 deaths, around 21 million illnesses and 70,000 hospitalizations each year, according to the Centers for Disease Control and Prevention (CDC). Globally, tens of millions of individuals contract Hepatitis A and Norovirus each year. Due to the nature of the virus, molecular techniques, such as RT-qPCR assays developed by CEERAM, are the most widely accepted detection method.
"As global leaders in food testing products, we recognise the importance of public confidence in food safety," said Nir Nimrodi, Life Technologies' Vice President and General Manager Animal Health & Food Safety. "This global distribution deal with CEERAM broadens Life Technologies' already extensive portfolio of pathogen food safety solutions with these virus detection kits, providing food regulatory bodies and food manufacturers with access to these high quality products."
CEERAM will be recognised by the International Association for Food Protection (IAFP) with a Food Safety Innovations Award during its annual meeting taking place at the Charlotte Convention Center in Charlotte, N.C., July 28-31. For more information on CEERAM's RT-qPCR assays for the detection of Norovirus GI and Norovirus GII, Hepatitis A, and the Mengovirus Extraction Control Kit, visit the Life Technologies booth (#524) during the conference.
"CEERAM is taking a great step forward for the distribution of its CEERAMToolsTM range of RT-qPCR kits with its partner Life Technologies," said Benoit Lebeau, CEO at CEERAM. "This will increase our market presence and ease access to new business opportunities."
Streaming Protocol Makes Gene Data Sharing Future-ProofNews
The Large Scale Genomics Work Stream of the Global Alliance for Genomics and Health (GA4GH) has announced eight new implementations of its htsget protocol, a standard released in October 2017 for accessing large-scale genomic sequencing data online that does not depend on file transfers. The protocol and interoperability testing are reported in a paper released online this week in the journal Bioinformatics.
Antiviral Gene Vanquishes ZikaNews
It’s been known for years that humans and other mammals possess an antiviral gene called RSAD2 that prevents a remarkable range of viruses from multiplying. Now, researchers at Albert Einstein College of Medicine, part of Montefiore, have discovered the secret to the gene’s success: The enzyme it codes for generates a compound that stops viruses from replicating. The newly discovered compound, described in today’s online edition of Nature, offers a novel approach for attacking many disease-causing viruses.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.